Reena Shah , MD
Associate Professor of Clinical
Stetson Building
Suite 2300
260 Stetson Street
Cincinnati, Ohio 45267-0525
Phone 513-558-0156
Fax 513-558-4887
Email reena.shah@uc.edu
Education
Medical Degree: Tufts University School of Medicine
Bachelor's Degreee: Brandeis University Waltham, MA, 2001 (Neuroscience & Biology Magna Cum Laude)
Internship: University of Maryland Baltimore, MD, 2007 (Internal Medicine )
Residency: University of Maryland Medical Systems Baltimore, MD, 2010 (Neurology)
Certifications
United Council for Neurologic Subspecialties (Certification Date: 10-31-2014 )
American Board of Psychiatry and Neurology (Neurology) (Certification Date: 09-13-2010 ) - (Recertification Date: to 01-15-2022 )
Clinical Interests
Headache
Neurology
Atypical Facial Pain
Bell's Palsy
Botulinum Toxins
Brain Concussion
Cervicogenic Headaches
Chronic Daily Headaches
Cluster Headaches
Concussion
Concussion in Athletes
Exercise Headaches
Exertional Headaches
External Compression Headaches
Facial Nerve Disease
Facial Neuralgia
Hemicrania Continua
Hypnic Headaches
Ice cream Headaches
Intracranial Hypertension
Intracranial Vasospasm
Lewy Body Disease
Low Pressure Headaches (Intracranial Hypotension)
Medication Overuse Headaches
Meningioma
Migraine Disorders
Migraine with Aura
Migraine without Aura
Migraines
Multiple System Atrophy (MSA)
Muscular Atrophy
Normal Pressure Hydrocephalus
Occipital Neuralgia (ON)
Rebound Headache
Sex Headaches
Spinal Headaches
Syncope
Tension-Type Headaches
Thunderclap Headaches
Traumatic Brain Injury (TBI)
Trigeminal Autonomic Cephalalgias
Trigeminal Neuralgia (Tic douloureux)
Type II Trigeminal Neuralgia
Vascular Headaches
Wernicke Encephalopathy
Specialities
Headache
Neurology
Research and Practice Interests
General Neurology
Headache Medicine
Research Support
Grant: #NOE-TGN-201 Investigators:Shah, Reena 03-01-2022 -03-01-2025 NOEMA PHARMA A Phase II/III, multicentre, 8-week run-in phase followed by a 12-week, prospective, parallel-group, double-blind, randomized withdrawal, placebo-controlled study, with a 52 week open label extension, Role:PI 120172.44 Hold Level:Industry
Investigators:Shah, Reena -06-30-2022 Ohio Department of Rehabilitation and Correction A Phase II/III, multicentre, 8-week run-in phase followed by a 12-week, prospective, parallel-group, double-blind, randomized withdrawal, placebo-controlled study, with a 52 week open label extension, Role:PI 0.00 Hold Level:Ohio, State of
Publications
Peer Reviewed Publications
Shah, Reena S; Shin, Robert K; Castellani, Rudy J (2010. ) Granulocytic sarcoma mimicking HSV encephalitis.The neurologist, , 16 (5 ) ,319-21 More Information
Shah, Reena S; Cole, John W (2010. ) Smoking and stroke: the more you smoke the more you stroke.Expert review of cardiovascular therapy, , 8 (7 ) ,917-32 More Information
Shah, Reena S; Lee, Hyoung-Gon; Xiongwei, Zhu; Perry, George; Smith, Mark A; Castellani, Rudy J Current approaches in the treatment of Alzheimer's disease.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, , 62 (4 ) ,199-207 More Information
Presentations
Lecture
Shah, Reena, MD (06-2015. ) Secondary Headache .University of Cincinnati Medical Center. UC. Level:University
Shah, Reena, MD (09-2012. ) Post Traumatic Headache .University of Cincinnati Medical Center.
(09-2012. ) Dizziness: Basic Principles of the Vestibular system and Evaluation and Management of the Dizzy Patient .University of Cincinnati Medical Center.
Shah, Reena, MD (01-2011. ) Acute Stroke Management. Saint Joseph East, Lexington, Kentucky.
Contact Information
Academic - Stetson Building
Suite 2300
Cincinnati
Ohio, 45267-0525
Phone: 513-558-0156
Fax: 513-558-4887
reena.shah@uc.edu
UC Health Physicians Office - Florence, KY
68 Cavalier Blvd.
Florence
Kentucky, 41042
Phone: 513-475-8730
Practice - UC Health Physicians Office
3113 Bellevue Avenue
Cincinnati
Ohio, 45219
Phone: 513-475-8730